LCTX:NYSEAMERICAN
Lineage Cell Therapeutics Inc
US$Â 0.95
arrow_upward
+1.03%(+0.0097) Siku 1
US$Â 0.96
arrow_upward
+0.89% (+0.0084)todayKabla ya soko
Imefungwa: 7 Okt, 16:00:00 GMT -4 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya LCTX...
Fungua
US$Â 0.94
Juu
US$Â 0.96
Chini
US$Â 0.92
Mtaji wa soko
239.12M
Wastani wa kiasi cha mauzo
1.35M
Kiasi cha mauzo ya hisa
170.00
Juu kwa wiki 52
US$Â 2.09
Chini kwa wiki 52
US$Â 0.88
EPS
-US$Â 0.14
Beta
1.60
Hisa za wawekezaji
252.91M
Idadi ya wafanyakazi
75
Fungua
US$Â 0.94
Juu
US$Â 0.96
Chini
US$Â 0.92
Mtaji wa soko
239.12M
Wastani wa kiasi cha mauzo
1.35M
Kiasi cha mauzo ya hisa
170.00
Juu kwa wiki 52
US$Â 2.09
Chini kwa wiki 52
US$Â 0.88
EPS
-US$Â 0.14
Beta
1.60
Hisa za wawekezaji
252.91M
Idadi ya wafanyakazi
75
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
The Lufkin Daily News
·
saa 1 iliyopita
FILE PHOTO: Traders react to the Fed rate announcement on the floor of the NYSE in New York
24/7 Wall St.
·
dakika 17 zilizopita
3 Stocks That Have More Than Doubled the S&P 500’s Return This Year
TradingView
·
dakika 35 zilizopita
US Futures Slump on Thursday
Yahoo Finance
·
dakika 32 zilizopita
Dell Turned $1,000 Into $11,641 in Five Years as AI Servers Crushed the S&P 500
Wasifu
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Kuhusu Lineage Cell Therapeutics Inc